TD Asset Management
VYGR icon

TD Asset Management’s Voyager Therapeutics VYGR Stock Holding History

TD Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,350
Closed -$174K – 1303
2025
Q4 		$174K Hold
44,350
– – ﹤0.01% 1226
2025
Q3 		$207K Sell
44,350
-31,980
-42% -$116K ﹤0.01% 1223
2025
Q2 		$237K Hold
76,330
– – ﹤0.01% 1174
2025
Q1 		$258K Sell
76,330
-38,600
-34% -$180K ﹤0.01% 1185
2024
Q4 		$652K Hold
114,930
– – ﹤0.01% 1157
2024
Q3 		$672K Sell
114,930
-46,998
-29% -$342K ﹤0.01% 1258
2024
Q2 		$1.28M Hold
161,928
– – ﹤0.01% 1116
2024
Q1 		$1.51M Buy
161,928
+28,426
+21% +$240K ﹤0.01% 1092
2023
Q4 		$1.13M Hold
133,502
– – ﹤0.01% 1158
2023
Q3 		$1.03M Buy
133,502
+66,751
+100% +$610K ﹤0.01% 1134
2023
Q2 		$764K Buy
66,751
+12,451
+23% +$129K ﹤0.01% 1181
2023
Q1 		$419K Hold
54,300
– – ﹤0.01% 1299
2022
Q4 		$331K Hold
54,300
– – ﹤0.01% 1343
2022
Q3 		$326K Hold
54,300
– – ﹤0.01% 1362
2022
Q2 		$321K Buy
+54,300
New +$367K ﹤0.01% 1348

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TD Asset Management's VYGR Position: Q1 2026 in Review

TD Asset Management sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 44,350 shares — an estimated $174K sold.

TD Asset Management first reported a position in VYGR in Q2 2022 and held it in 15 quarters. The position peaked at $1.51M in Q1 2024. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • TD Asset Management reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • TD Asset Management sold 44,350 Voyager Therapeutics shares in Q1 2026, an estimated $174K.
  • TD Asset Management first reported a position in Voyager Therapeutics in Q2 2022 and held it in 15 quarters.
  • TD Asset Management's Voyager Therapeutics position peaked at $1.51M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.